These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35313748)

  • 21. Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy.
    Abbaszadeh H; Ghorbani F; Derakhshani M; Movassaghpour AA; Yousefi M; Talebi M; Shamsasenjan K
    J Cell Physiol; 2020 Dec; 235(12):9230-9240. PubMed ID: 32557631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.
    Sabapathy V; Sundaram B; V M S; Mankuzhy P; Kumar S
    PLoS One; 2014; 9(4):e93726. PubMed ID: 24736473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
    Musiał-Wysocka A; Kot M; Sułkowski M; Badyra B; Majka M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Nonmuscle Myosin II in Migration of Wharton's Jelly-Derived Mesenchymal Stem Cells.
    Arora S; Saha S; Roy S; Das M; Jana SS; Ta M
    Stem Cells Dev; 2015 Sep; 24(17):2065-77. PubMed ID: 25923805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
    Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
    J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Wharton's jelly-derived mesenchymal stem cells prevent pregnancy loss in a rat by JAK/STAT-mediated immunomodulation.
    Ding X; Wu R; Jin B; Zhu C; Zhang Y; Yang X
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2417-2426. PubMed ID: 37464974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
    Pu L; Meng M; Wu J; Zhang J; Hou Z; Gao H; Xu H; Liu B; Tang W; Jiang L; Li Y
    Stem Cell Res Ther; 2017 Mar; 8(1):72. PubMed ID: 28320452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.
    Pochon C; Notarantonio AB; Laroye C; Reppel L; Bensoussan D; Bertrand A; Rubio MT; D'Aveni M
    J Cell Mol Med; 2022 Mar; 26(5):1339-1350. PubMed ID: 35088933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
    Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
    Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs).
    Lech W; Sarnowska A; Kuczynska Z; Dabrowski F; Figiel-Dabrowska A; Domanska-Janik K; Buzanska L; Zychowicz M
    Sci Rep; 2020 Oct; 10(1):16946. PubMed ID: 33037314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro anti-leukemic effect of Wharton's jelly derived mesenchymal stem cells.
    Süleymanoğlu M; Erol Bozkurt A; Abatay Sel F; Özdemir İA; Savran Oğuz F; Kuruca DS; Aktaş Z; Karakaş Z; Öncül MO
    Mol Biol Rep; 2024 Apr; 51(1):595. PubMed ID: 38683436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H3K9ac of TGFβRI in human umbilical cord: a potential biomarker for evaluating cartilage differentiation and susceptibility to osteoarthritis via a two-step strategy.
    Qi Y; Li B; Wen Y; Yang X; Chen B; He Z; Zhao Z; Magdalou J; Wang H; Chen L
    Stem Cell Res Ther; 2021 Mar; 12(1):163. PubMed ID: 33663609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
    Sun B; Shi L; Shi Q; Jiang Y; Su Z; Yang X; Zhang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):314. PubMed ID: 30442201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Cell-Derived Matrices on Growth and Differentiation of Human Wharton's Jelly-Derived Mesenchymal Stem Cells.
    Selvaraj S; Rupert S; Nandabalan SK; Anbalagan C; Rajaram PS; Satyanesan J; Vennila R; Rajagopal S
    Cells Tissues Organs; 2024; 213(1):67-78. PubMed ID: 35908543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells.
    Thakur G; Bok EY; Kim SB; Jo CH; Oh SJ; Baek JC; Park JE; Kang YH; Lee SL; Kumar R; Rho GJ
    Eur J Cell Biol; 2022; 101(3):151245. PubMed ID: 35667339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy.
    Tang XL; Nasr M; Zheng S; Zoubul T; Stephan JK; Uchida S; Singhal R; Khan A; Gumpert A; Bolli R; Wysoczynski M
    Stem Cell Rev Rep; 2023 Oct; 19(7):2429-2446. PubMed ID: 37500831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular matrix derived from Wharton's Jelly-derived mesenchymal stem cells promotes angiogenesis via integrin αVβ3/c-Myc/P300/VEGF.
    Ma B; Wang T; Li J; Wang Q
    Stem Cell Res Ther; 2022 Jul; 13(1):327. PubMed ID: 35851415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.